PORTOLA PHARMACEUTICALS INC's ticker is PTLA and the CUSIP is 737010108. A total of 153 filers reported holding PORTOLA PHARMACEUTICALS INC in Q4 2016. The put-call ratio across all filers is 0.60 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $1,834,000 | -6.8% | 67,002 | +3.3% | 0.25% | -15.2% |
| Q2 2019 | $1,968,000 | +2.4% | 64,879 | +3.1% | 0.30% | -1.3% |
| Q1 2019 | $1,921,000 | -1.4% | 62,958 | +0.0% | 0.30% | -4.2% |
| Q4 2018 | $1,948,000 | +120.4% | 62,936 | +37.3% | 0.31% | +94.4% |
| Q3 2018 | $884,000 | -38.5% | 45,847 | +20.5% | 0.16% | -45.4% |
| Q2 2018 | $1,437,000 | +411.4% | 38,033 | +342.0% | 0.30% | +375.8% |
| Q1 2018 | $281,000 | +5.6% | 8,605 | -62.8% | 0.06% | -12.7% |
| Q4 2017 | $266,000 | -23.6% | 23,109 | +2.5% | 0.07% | -26.8% |
| Q3 2017 | $348,000 | +65.7% | 22,542 | +501.8% | 0.10% | +61.7% |
| Q2 2017 | $210,000 | -95.8% | 3,746 | +2781.5% | 0.06% | +252.9% |
| Q1 2017 | $4,953,000 | -93.6% | 130 | -96.2% | 0.02% | -32.0% |
| Q3 2016 | $77,312,000 | +37.5% | 3,430 | -27.9% | 0.02% | +257.1% |
| Q2 2016 | $56,224,000 | – | 4,760 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Fernwood Investment Management, LLC | 232,952 | $5,498,000 | 5.39% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 3,673,727 | $86,700,000 | 3.41% |
| Redmile Group, LLC | 1,466,537 | $34,610,000 | 3.31% |
| SECTORAL ASSET MANAGEMENT INC | 1,229,382 | $29,013,000 | 3.00% |
| HARVEY CAPITAL MANAGEMENT INC | 206,530 | $4,874,000 | 2.44% |
| Marcus Capital, LLC | 75,150 | $1,774,000 | 1.87% |
| Cormorant Asset Management, LP | 396,000 | $9,346,000 | 1.32% |
| Rail-Splitter Capital Management, LLC | 221,414 | $5,225,000 | 1.25% |
| Temasek Holdings (Private) Ltd | 6,583,568 | $155,372,000 | 1.21% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 636,526 | $15,022,000 | 0.84% |